Cargando…
Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827194/ https://www.ncbi.nlm.nih.gov/pubmed/35139906 http://dx.doi.org/10.1186/s13063-022-06073-7 |
| _version_ | 1784647577801588736 |
|---|---|
| author | Mera-Cordero, Francisco Bonet-Monne, Sara Almeda-Ortega, Jesús García-Sangenís, Ana Cunillera-Puèrtolas, Oriol Contreras-Martos, Sara Alvarez-Muñoz, Gemma Monfà, Ramon Balanzó-Joué, Marina Morros, Rosa Salvador-Gonzalez, Betlem |
| author_facet | Mera-Cordero, Francisco Bonet-Monne, Sara Almeda-Ortega, Jesús García-Sangenís, Ana Cunillera-Puèrtolas, Oriol Contreras-Martos, Sara Alvarez-Muñoz, Gemma Monfà, Ramon Balanzó-Joué, Marina Morros, Rosa Salvador-Gonzalez, Betlem |
| author_sort | Mera-Cordero, Francisco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8827194 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88271942022-02-10 Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol Mera-Cordero, Francisco Bonet-Monne, Sara Almeda-Ortega, Jesús García-Sangenís, Ana Cunillera-Puèrtolas, Oriol Contreras-Martos, Sara Alvarez-Muñoz, Gemma Monfà, Ramon Balanzó-Joué, Marina Morros, Rosa Salvador-Gonzalez, Betlem Trials Correction BioMed Central 2022-02-09 /pmc/articles/PMC8827194/ /pubmed/35139906 http://dx.doi.org/10.1186/s13063-022-06073-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Mera-Cordero, Francisco Bonet-Monne, Sara Almeda-Ortega, Jesús García-Sangenís, Ana Cunillera-Puèrtolas, Oriol Contreras-Martos, Sara Alvarez-Muñoz, Gemma Monfà, Ramon Balanzó-Joué, Marina Morros, Rosa Salvador-Gonzalez, Betlem Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol |
| title | Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol |
| title_full | Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol |
| title_fullStr | Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol |
| title_full_unstemmed | Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol |
| title_short | Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol |
| title_sort | correction to: double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long covid: e-speranza covid project study protocol |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827194/ https://www.ncbi.nlm.nih.gov/pubmed/35139906 http://dx.doi.org/10.1186/s13063-022-06073-7 |
| work_keys_str_mv | AT meracorderofrancisco correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT bonetmonnesara correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT almedaortegajesus correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT garciasangenisana correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT cunillerapuertolasoriol correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT contrerasmartossara correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT alvarezmunozgemma correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT monfaramon correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT balanzojouemarina correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT morrosrosa correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol AT salvadorgonzalezbetlem correctiontodoubleblindplacebocontrolledrandomizedclinicaltrialtoassesstheefficacyofmontelukastinmildtomoderaterespiratorysymptomsofpatientswithlongcovidesperanzacovidprojectstudyprotocol |